NEI Research News

The K99/R00 provides a runway for postdocs seeking to transition from mentored positions to tenure track positions at academic institutions in the U.S.

Members of the National Eye Institute's Audacious Goals Initiative (AGI) published an outline of milestones to reach before commencing clinical trials of regenerative therapies for retinal disease.

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

Ruchi Sharma, Ph.D., a staff scientist in the NEI Ocular and Stem Cell Translational Section, received an award from the Knights Templar Eye Foundation (KTEF), a charity sponsored by the Grand Encampment of Knights Templar.

Using a new experimental technique to fix faulty eye cells, a team led by University of Wisconsin researchers was able to repair a gene mutation that causes one form of childhood blindness.

The Lasker Foundation cited a trio of scientists, who with NEI funding, developed OCT, one of the most widely used technologies for imaging the eye.

Research suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential.

Researchers found that diabetes, age-related health conditions and other metabolic disorders can lead to a buildup of cholesterol in the retina, which could contribute to diabetic retinopathy.

Designed by researchers at NYU, Commute Booster routes public-transportation users through the “middle mile” — the part of a journey inside subway stations or other similar transit hubs.

A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the eye.